Usual Causes of Fusiform Bronchial Artery Aneurysm
Fusiform bronchial artery aneurysms are most commonly caused by chronic inflammatory conditions—particularly bronchiectasis, chronic pulmonary infections (especially tuberculosis), and inflammatory lung diseases—though they can also arise from congenital vascular malformations or atherosclerotic disease.
Primary Etiologic Categories
Chronic Inflammatory/Infectious Conditions
The most frequent underlying causes involve chronic inflammatory processes that lead to arterial wall weakening and subsequent aneurysmal dilatation:
Bronchiectasis 1: The chronic inflammatory state with recurrent bacterial colonization leads to increased bronchial arterial proliferation and arteriovenous malformations. The actions of inflammatory mediators, elastase, and collagenase destroy the elastic and muscular components of vessel walls, predisposing to aneurysm formation.
Chronic pulmonary infections: Tuberculosis historically represents a major cause, though its prevalence varies geographically. The chronic inflammatory response damages vessel walls through similar mechanisms as bronchiectasis.
Inflammatory lung diseases: Conditions causing chronic pulmonary inflammation create an environment conducive to vascular remodeling and aneurysm development.
Congenital Vascular Malformations
Primary racemose hemangioma of the bronchial artery represents a rare congenital cause 2. These lesions present with tortuous arteries and multiple fusiform aneurysms of varying sizes, sometimes with marked thrombus formation. The case literature demonstrates these can occur in asymptomatic patients and may be discovered incidentally.
Bronchial-Pulmonary Arterial Communications
Idiopathic bronchial artery aneurysms with connections to the pulmonary artery 3, 4 represent another distinct entity. These demonstrate a three-layer vascular structure connecting both arterial systems and may present with dilated, hypervascular submucosal vessels visible on bronchoscopy.
Important Clinical Distinctions
True vs. Pseudoaneurysms
It's critical to distinguish between:
- True aneurysms: Involve all three vessel wall layers and typically arise from chronic inflammatory conditions
- Pseudoaneurysms 5, 6: Result from vessel wall disruption with contained rupture, often associated with trauma, infection, or iatrogenic injury
Pseudoaneurysms carry higher rupture risk and require urgent intervention.
Atherosclerotic Disease
While the provided guidelines extensively discuss atherosclerotic aneurysms in larger vessels (particularly the aorta) 7, atherosclerotic involvement of bronchial arteries is less commonly documented but remains a potential etiology, particularly in elderly patients with systemic atherosclerosis.
Key Pathophysiologic Mechanism
The common pathway involves chronic inflammation leading to destruction of elastic and muscular components of the arterial wall 1. This is mediated by:
- Neutrophils and T lymphocytes
- Monocyte-derived cytokines
- Elastase and collagenase activity
The weakened vessel wall then dilates under arterial pressure, creating the fusiform morphology.
Clinical Pitfalls
Do not assume all bronchial artery aneurysms are symptomatic—many are discovered incidentally on imaging 2. However, once identified, treatment is generally indicated regardless of symptoms due to rupture risk and potential for life-threatening hemoptysis 6.
Consider underlying systemic conditions: Always evaluate for bronchiectasis, chronic infections, vasculitis (particularly Behçet disease 8), and connective tissue disorders when bronchial artery aneurysms are identified.